278a-eu-geschw
Dieses Dokument ist Teil der Anfrage „Briefverkehr mit BioNtech“
&RQWDFW 7HO )D[ 6HFUHWDULDW1&/%LRORJLFDOV#VFLHQVDQREH 7(67 (PDLOJHQHYLHYHZDHWHUORRV#VFLHQVDQREH 4XDOLW\RI9DFFLQHVDQG%ORRG3URGXFWV I 9D DFF FFLLQ QHHVDQG%ORRG G 3U 3 RGX RG GXF (82)),&,$/&21752/$87+25,7<%$7&+5(/($6(&(57,),&$7( (8 2)) )) ),& ,&,$ ,$ $/ &2 &21752/ )25,00812/2*,&$/352'8&76 (8(($2)),&,$/&21752/$87+25,7<%$7&+5(/($6(&(57,),&$7(±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igitally signed by 'DWHRILVVXH Date: 2022.01.14 15:52:23 +01'00' 1DPHDQGIXQFWLRQRIVLJQDWRU\ &HUWLILFDWHQXPEHU%(5(9 6XFKDVEDWFKQXPEHURIILQDOEXON )250,,(Y 'DWHRIDSSOLFDWLRQ S